Shamburg News · 8-K filed Nov 9, 2026, 4:11 PM EST

ZeroStack Corp. Agrees to Sell Phatebo GmbH to New Horizon Pharma for €2.15 Million

ZSTK · ZeroStack Corp.

  • Material agreement
  • Acquisition
  • Materiality: medium

On November 3, 2026, ZeroStack Corp. entered into a Share Purchase and Transfer Agreement with New Horizon Pharma B.V. and Phatebo GmbH to sell all outstanding shares of Phatebo, which the Company wholly owns. The aggregate purchase price is €2,150,000. Closing is subject to German foreign direct investment clearance and other customary closing conditions.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001062993-26-005837.

Written from the filing by Shamburg Markets. Figures are as reported by the company.